Thu, October 28, 2021
Wed, October 27, 2021
Tue, October 26, 2021
Mon, October 25, 2021
Sun, October 24, 2021
Fri, October 22, 2021
Thu, October 21, 2021

Anupam Rama Upgraded (VIR) to Hold and Increased Target to $37 on, Oct 25th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. and-increased-target-to-37-on-oct-25th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Anupam Rama of JP Morgan, Upgraded "Vir Biotechnology, Inc." (VIR) to Hold and Increased Target from $29 to $37 on, Oct 25th, 2021.

Anupam has made no other calls on VIR in the last 4 months.



There are 2 other peers that have a rating on VIR. Out of the 2 peers that are also analyzing VIR, 1 agrees with Anupam's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Paul Choi of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $62 on, Wednesday, September 22nd, 2021


This is the rating of the analyst that currently disagrees with Anupam


  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $71 on, Friday, August 6th, 2021

Publication Contributing Sources